![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Chongqing Huapont Pharmaceutical Co., Ltd. Chongqing Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Acitretin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-038 - Rev 02
This Chemical Type CEP, issued on August 17, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1385 associated with this CEP further emphasizes